Searched for *.

1. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar (Publications)

   Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar

   Relevance:

   BACKGROUND: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplementary tool to conventional prevention of cholera. Dukoral, a killed whole-cell two-dose OCV, was us

2. Simulation of the cost-effectiveness of malaria vaccines (Publications)

   Simulation of the cost-effectiveness of malaria vaccines

   Relevance:

   BACKGROUND: A wide range of possible malaria vaccines is being considered and there is a need to identify which vaccines should be prioritized for clinical development. An important element of the inf

3. Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from <em>Mycobacterium ulcerans</em> by homologous... (Publications)

   Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from <em>Mycobacterium ulcerans</em> by homologous protein boosting

   Relevance:

   Vaccination with plasmid DNA encoding Ag85A from M. bovis BCG can partially protect C57BL/6 mice against a subsequent footpad challenge with M. ulcerans. Unfortunately, this cross-reactive protection

4. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania (Publications)

   Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania

   Relevance:

   The prevalence of antibodies to human immunodeficiency virus (HIV = LAV/HTLV-III) in a rural population from the Ifakara area in southeastern Tanzania was investigated. Sera from 286 individuals colle

5. Evaluation des nationalen Krebsbekämpfungsprogramms : Phase II, 2000 - 2002 : Studie 4 : Darmkrebs in der Schweiz : sekundäre Analyse der verfügbaren... (Publications)

   Evaluation des nationalen Krebsbekämpfungsprogramms : Phase II, 2000 - 2002 : Studie 4 : Darmkrebs in der Schweiz : sekundäre Analyse der verfügbaren Indikatoren von Darmkrebs

   Relevance:

6. Laboratory and field trials at Ifakara (Kilombero District, Tanzania) on the plant molluscicide <em>Swartzia madagascariensis</em> (Publications)

   Laboratory and field trials at Ifakara (Kilombero District, Tanzania) on the plant molluscicide <em>Swartzia madagascariensis</em>

   Relevance:

   The molluscicidal activity of crushed seed pods of Swartzia madagascariensis was assessed by laboratory and field trials. Mature dry seed pods were ground and extracted in tap water for 24 h. Water ex

7. Tätigkeitserfassung der frei praktizierenden Hebammen der Schweiz: Statistik des SHV 2008 (Publications)

   Tätigkeitserfassung der frei praktizierenden Hebammen der Schweiz: Statistik des SHV 2008

   Relevance:

8. Access to medicines and out of pocket payments for primary care: evidence from family users in rural Tajikistan (Publications)

   Access to medicines and out of pocket payments for primary care: evidence from family users in rural Tajikistan

   Relevance:

   Background:

9. Molecular characterization of <em>Mycobacterium bovis</em> strains isolated from cattle slaughtered at two abattoirs in Algeria (Publications)

   Molecular characterization of <em>Mycobacterium bovis</em> strains isolated from cattle slaughtered at two abattoirs in Algeria

   Relevance:

   BACKGROUND: Bovine Tuberculosis is prevalent in Algeria despite governmental attempts to control the disease. The objective of this study was to conduct, for the first time, molecular characterization

10. A review of malaria vaccine clinical projects based on the WHO rainbow table (Publications)

    A review of malaria vaccine clinical projects based on the WHO rainbow table

    Relevance:

    Development and Phase 3 testing of the most advanced malaria vaccine, RTS,S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of several research malaria vaccines have